Drug intelligence / Profile preview

Optium DBM Gel

Development stage
Unknown
Lead developer
LifeNet Health
Administration
Topical
01

Overview

Optium DBM Gel is a bone graft substitute developed by LifeNet Health, designed for filling bony voids or gaps in the musculoskeletal system. It is a biologic tissue-based product composed of particulate demineralized bone matrix (DBM) combined with a glycerol carrier. The DBM is processed using proprietary Precise Aseptic Demineralization (PAD) technology to achieve residual calcium levels of 1-4%, which preserves its osteoinductive potential. The gel formulation is flowable and moldable, providing an osteoconductive scaffold that supports bone healing and fusion in applications such as joint reconstruction, trauma, and posterolateral spine fusion. It is sterilized using Allowash XG technology and is provided ready-to-use without requiring rehydration or thawing.

Brand names
Optium DBM Gel
Other names
Optium DBM
02

Targets

BMPR (Bone morphogenetic protein receptor)

Beyond the preview

Go deeper on Optium DBM Gel.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Optium DBM Gel.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call